Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: Treatment failure and resistance in Malawi remain subject for debate

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7450.1259-a (Published 20 May 2004) Cite this as: BMJ 2004;328:1259
  1. P Ringwald, medical officer (ringwaldp@who.int)
  1. Roll Back Malaria Department, World Health Organization, 1211 Geneva 27, Switzerland

    EDITOR—The methods applied to enhance the interpretation of the data by Plowe et al deserve comment.1

    The World Health Organization has developed several standardised protocols to assess the efficacy of antimalarial drugs, which are intended to determine treatment failures and not resistance patterns of the parasite. Recently, WHO published a revised protocol, giving clear indications of outcome classifications and the target groups (children under 5 years …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription